US Stock MarketDetailed Quotes

ASMB Assembly Biosciences

Watchlist
  • 14.530
  • -0.190-1.29%
Close May 17 16:00 ET
  • 14.530
  • 0.0000.00%
Post 16:00 ET
80.11MMarket Cap-1373P/E (TTM)

About Assembly Biosciences Company

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Company Profile

SymbolASMB
Company NameAssembly Biosciences
Listing DateDec 17, 2010
Issue Price6.00
Founded2005
CEOMr. Jason A. Okazaki
MarketNASDAQ
Employees65
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressTwo Tower Place,7th floor
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-833-509-4583
Websitehttp://www.assemblybio.com

Company Executives

  • Name
  • Position
  • Salary
  • Jason A. Okazaki
  • Director, President, Chief Executive Officer and Principal Financial Officer
  • 1.37M
  • William E. Delaney, PhD
  • Chief Scientific Officer
  • 811.82K
  • Nicole S White
  • Chief Manufacturing Officer
  • 705.51K
  • Anuj Gaggar
  • Chief Medical Officer
  • --
  • Jeanette M. Bjorkquist
  • Executive Director, Accounting and Treasury and Principal Accounting Officer
  • --
  • William R. Ringo, Jr
  • Chairman of the Board
  • 122.08K
  • Dr. John G. McHutchison, A.O.,M.D.
  • Director
  • 64.58K
  • Robert D. Cook, II
  • Director
  • --
  • Dr. Tomas Cihlar, PhD
  • Director
  • --
  • Dr. Michael Houghton
  • Independent Director
  • 59.58K
  • Dr. Susan Mahony, M.B.A.,PhD
  • Independent Director
  • 74.58K
  • Dr. Lisa R. Johnson-Pratt
  • Independent Director
  • 64.58K
  • Anthony E. Altig
  • Independent Director
  • 79.58K
  • Gina Consylman
  • Independent Director
  • 72.08K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg